Boston Partners

Boston Partners’s Charles River Laboratories CRL Stock Holding History

Boston Partners’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-37,394	Closed	-$2.96M	–	710
2015 Q1	$2.96M	Sell	37,394 -8,615	-19%	-$636K	﹤0.01%	578
2014 Q4	$2.93M	Sell	46,009 -2,152	-4%	-$135K	﹤0.01%	602
2014 Q3	$2.88M	Hold	48,161	–	–	﹤0.01%	592
2014 Q2	$2.58M	Buy	48,161 +543	+1%	+$29.8K	﹤0.01%	606
2014 Q1	$2.87M	Sell	47,618 -4,667	-9%	-$272K	0.01%	591
2013 Q4	$2.77M	Hold	52,285	–	–	0.01%	587
2013 Q3	$2.42M	Sell	52,285 -30	-0.1%	-$1.38K	0.01%	579
2013 Q2	$2.15M	Buy	+52,315	New	+$2.24M	0.01%	590

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $92.2B AUM 15.8% 1-Year Est. Return

Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return